Research LetterSevere acute respiratory syndrome coronavirus 2 immunity: infective and naive incidence in fertility clinics after lockdown
Cited by (0)
R.F. and D.S. contributed equally to this work.
R.K., D.V., and J.C. are employed by Igenomix USA LLC, and C.S. is the Head of the Scientific Advisory Board of Igenomix. R.F. and D.S. are employees in the different fertility centers that participated in this study.
This study has been funded by Igenomix USA LLC, which is the promoter of the study.
The findings in this paper were presented as poster at the “Virtual Congress ASRM 2020,” October 21, 2020.
ClinicalTrials.gov (ID NCT 04466644); http://www.clinicaltrials.gov.
© 2021 Elsevier Inc. All rights reserved.